Our in silico analysis of IFN-treated melanoma tissues of TCGA revealed the differential expression of five members of our 79 IFN-res DEGs in IFN-treated melanoma tissues: IRG SOX4 and non-IRGs WFDC1, BCAN, RPE65, and MAPT. This evidence concerns the gene IFNA1 and melanoma.